FDC Limited (FDC)
₹473.45
INR-9.55(-1.98%)
As of February 5, 2025 9:59:00 AMAbout FDC Limited
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
3.74
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
10.97
+3.2% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
7754.64 CrINR
Total market value of the company's outstanding shares
Employees
6659
Total number of full-time employees worldwide
CEO
Mr. Ameya Ashok Chandavarkar
Chief Executive Officer of the company